Testing SNPs in targeted drug development

DOI10.1201/9780429030888-15MaRDI QIDQ5031202zbMATH OpenOpenAlexFDO

Authors Ying Ding, Yue Wei, Xinjun Wang, Jason C. Hsu

Publication date 18 February 2022

Published in Handbook of Multiple Comparisons (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1201/9780429030888-15

Mathematics Subject Classification ID

Paired and multiple comparisons; multiple testing (62J15) Applications of statistics to biology and medical sciences; meta analysis (62P10) Protein sequences, DNA sequences (92D20)

Recommendations

• Confident inference for SNP effects on treatment efficacy
• Discussion on the issue of sample size determination for a targeted to an untargeted and to a mixed effect model-based clinical trial design
• Testing SNPs and sets of SNPs for importance in association studies
• Methods for analysis and visualization of SNP genotype data for complex diseases
• A penalized likelihood approach for investigating gene-drug interactions in pharmacogenetic studies

Cited in

(1)

• Discussion on the issue of sample size determination for a targeted to an untargeted and to a mixed effect model-based clinical trial design

This page was built for publication: Testing SNPs in targeted drug development

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5031202)